Lundbeck
HLUN-B.CO
#2596
Rank
A$9.97 B
Marketcap
A$10.51
Share price
0.63%
Change (1 day)
10.63%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): A$1.32 Billion

According to Lundbeck's latest financial reports the company's current earnings are A$3.61 Billion. In 2024 the company made an earning of A$0.83 Billion, an increase over its 2023 earnings that were of A$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.32 B59%
2024 A$0.83 B25.74%
2023 A$0.66 B21.77%
2022 A$0.54 B31.57%
2021 A$0.41 B-4.61%
2020 A$0.43 B-45.06%
2019 A$0.78 B-34.04%
2018 A$1.19 B12.83%
2017 A$1.06 B93.99%
2016 A$0.54 B-137.28%
2015 -A$1.47 Billion-1246.24%
2014 A$0.12 B-72.36%
2013 A$0.46 B4.38%
2012 A$0.44 B-55.18%
2011 A$0.98 B5.65%
2010 A$0.93 B-5.9%
2009 A$0.99 B